Issue 6, 2019

Protein biomaterials for theranostic applications

Abstract

Protein biomaterials have been used for a wide range biomedical applications due to their intrinsic biocompatibility, versatility and higher order structure. Multifunctional theranostic agents fabricated by incorporating the diagnostic modalities and drug payloads in protein nanoformulations have garnered significant attention in recent years. Protein-based theranostic agents manifest high target specificity, enhanced blood circulation and reduce reticuloendothelial system elimination. This review focuses on the fabrication of peptide- and protein-based nanoformulations for imaging guided therapy.

Graphical abstract: Protein biomaterials for theranostic applications

Article information

Article type
Review Article
Submitted
16 Oct 2019
Accepted
13 Nov 2019
First published
13 Nov 2019

Mol. Syst. Des. Eng., 2019,4, 1074-1094

Author version available

Protein biomaterials for theranostic applications

K. Punia, J. B. Kronenberg and J. K. Montclare, Mol. Syst. Des. Eng., 2019, 4, 1074 DOI: 10.1039/C9ME00143C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements